Gu Xiaoli, Chen Menglei, Liu Minghui, Zhang Zhe, Zhao Weiwei, Cheng Wenwu
Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, China.
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Am J Hosp Palliat Care. 2020 Apr;37(4):266-271. doi: 10.1177/1049909119867281. Epub 2019 Aug 4.
The American Society of Clinical Oncology recently recommends patients with metastatic non-small cell lung cancer (NSCLC) should be offered palliative care services earlier. We sought to investigate the timing of palliative care referral of Chinese patients with NSCLC in our center.
Retrospective medical data including demographic characteristics and referral information were collected for analysis. Overall survival (OS) was calculated as the time since cancer diagnosis till patient's death. The time interval from palliative care (PC) referral to a patient's death (PC-D) was calculated. The PC-D/OS ratio was calculated to illustrate the comparison of the duration of PC in the overall length of disease.
The mean age of 155 patients with advanced NSCLC was 62.83 years. Before referral to PC, 128 patients received anticancer treatment including surgeon (46.5%). Sixty-three (40.6%) patients died in palliative care unit. The median OS of 144 patients with end cutoff was 19 months (mean = 31.49, 95% confidence interval [CI] = 25.86-37.12). The median PC-D was 41 days (mean = 73.84, 95% CI = 60.37-87.40). The mean interval of PC-D/OS of 144 patients with definitely death time was 0.22 (SD: 0.27, 95% CI: 0.17-0.26). The median interval was 0.089. More than half of patients (n = 75, 51.8%) underwent PC less than 1% time (PC-D/OS < 0.1) of their whole disease course. Patients who were indigenous to Shanghai ( = .013) and who had brain metastasis ( = .072) had the potential longer PC-D/OS ratio. A high proportion of patients reported loss of appetite (92.8%) and fatigue (91.4%) at the initial of referral to PC.
This retrospective study, in a population of patients with advanced NSCLC, gave detailed information about PC services in a tertiary cancer center.
美国临床肿瘤学会最近建议,转移性非小细胞肺癌(NSCLC)患者应更早接受姑息治疗服务。我们试图调查我院NSCLC中国患者接受姑息治疗转诊的时机。
收集包括人口统计学特征和转诊信息在内的回顾性医疗数据进行分析。总生存期(OS)计算为从癌症诊断到患者死亡的时间。计算从姑息治疗(PC)转诊到患者死亡(PC-D)的时间间隔。计算PC-D/OS比值以说明姑息治疗持续时间在疾病总时长中的比较情况。
155例晚期NSCLC患者的平均年龄为62.83岁。在转诊至姑息治疗之前,128例患者接受了抗癌治疗,其中包括手术治疗(46.5%)。63例(40.6%)患者在姑息治疗病房死亡。144例有最终截止数据的患者的中位总生存期为19个月(均值 = 31.49,95%置信区间[CI] = 25.86 - 37.12)。中位PC-D为41天(均值 = 73.84,95%CI = 60.37 - 87.40)。144例有明确死亡时间的患者的PC-D/OS平均间隔为0.22(标准差:0.27,95%CI:0.17 - 0.26)。中位间隔为0.089。超过一半的患者(n = 75,51.8%)接受姑息治疗的时间少于其整个病程的1%(PC-D/OS < 0.1)。上海本地患者(P = 0.013)和有脑转移的患者(P = 0.072)的PC-D/OS比值可能更长。在转诊至姑息治疗初期,很大比例的患者报告有食欲不振(92.8%)和疲劳(91.4%)症状。
这项针对晚期NSCLC患者群体的回顾性研究,给出了三级癌症中心姑息治疗服务的详细信息。